Jason Schwartz is an Oncology physician affiliated with Vanderbilt University Medical Center. OpenAlex indexes 34 publications with 843 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372320001
Telephone
615-936-2000Provider last certified this registry record 23 Mar 2022.
Clinical trials
- Liver Transplantation for Cholangiocarcinoma
Sponsor: University of Utah
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AbbVie Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations
Vanderbilt University Medical Center
FY2024$148,716K08HL150282 - Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations
Vanderbilt University Medical Center
FY2023$148,716K08HL150282 - Hematopoietic consequences of gain-of-function SAMD9 and SAMD9L mutations
Vanderbilt University Medical Center
FY2022$148,716K08HL150282
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in mice
Journal of Clinical Investigation
2022 - The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms
Nature Communications
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center
Brian Rini, MD
Vanderbilt University Medical Center
William Schaffner, MD
Vanderbilt University Medical Center
Jordan Berlin, MD
Vanderbilt University Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”